Latest Occlutech News & Updates
See the latest news and media coverage for Occlutech. We track all announcements, press releases, and industry mentions in real time, all in one place.
Minimally invasive cardiac implant manufacturer
occlutech.com- Headquarters
- Helsingborg, Sweden
- Founded year
- 2003
- Company type
- Private company
- Number of employees
- 225–500
Latest news about Occlutech
Company announcements
-
Occlutech publishes OCCLUFLEX study design manuscript
The study is the first randomized comparison of U.S. approved PFO occluders versus Flex II Occluder, including patients over 60. FDA submission is planned for 2026.
-
Occlutech appoints Thomas J. Bogenschütz as Chairman
He brings over 30 years of MedTech experience, including CEO roles at MEDIRA and prior positions at CryoLife and JOTEC. The appointment strengthens governance for growth.
-
Occlutech announces commercial ASD Occluder implantations in the U.S
Procedures occurred at leading cardiac centers post-FDA approval in December 2023. The device shows positive outcomes and low complications. Occlutech partners with B. Braun for U.S. distribution.
-
Occlutech announces FDA approval of ASD Occluder and Pistol Pusher
The devices treat atrial septal defects minimally invasively. Commercialization begins with B. Braun in the US market.
Media coverage
-
Occlutech to gain Alkem as majority shareholder
Indian pharmaceutical company Alkem MedTech plans to acquire a majority stake in Swiss medtech company Occlutech. Alkem intends to buy up to 55% of Occlutech...
-
India s Alkem Labs unit to buy up to 55% of Occlutech for $118 million
BENGALURU, Feb 13 (Reuters) - Alkem Laboratories' medical devices unit will buy up to a 55% stake in...
-
Alkem Arm Makes Binding Offer to Acquire 51-55% Stake in Swiss Medtech Firm Occlutech
Alkem Laboratories Limited announced that its wholly owned subsidiary, Alkem Medtech Private Limited, has made a binding offer dated February 13, 2026, to acquire between...
-
India's Alkem Laboratories unit to buy up to 55% stake in Occlutech Holding for 99.4 million euros
Alkem Laboratories' medical devices unit will buy a stake of up to 55% in Switzerland-based Occlutech Holding for 99.4 million euros ($117.9 million), the pharmaceutical...
Track Occlutech and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Occlutech competitors & trending companies
Browse news for competitors to Occlutech and other trending companies.
Edwards
Socime Medical
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore
BlueConic
Amperity
Wero
BLIK
EPI
Swish
Affirm
Brite Payments
TCS
Overview Energy
Adfin
Ineffable Intelligence
Mechanize
Hexatronic
Alimak Group
Lindab Group
NYAB
Noon Energy
Nordan AI
Mips
Vexlum